Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

GSTP1-modified exosomes derived from ADMSCs relieve LPS-induced acute lung injury.

Guan H., Du J., Wang X., Zhang Z., Zhou W., Wang F.

Animal Study on Chronic Inflammation, published in Cytotechnology (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Cytotechnology (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41357851
DOI
10.1007/s10616-025-00863-y

Abstract (original English)

Acute lung injury (ALI) is a life-threatening critical condition with high mortality. Adipose mesenchymal stem cell (ADMSC)-derived exosomes hold great potential for clinical therapy and drug delivery. Given that glutathione S-transferase Pi 1 (GSTP1), a key enzyme in oxidative stress response, is highly expressed in lung tissue and has been implicated in mitigating inflammatory and oxidative damage. However, the research on GSTP1-mediated ADMSC-derived exosomes in ALI is still blank. ADMSCs were characterized using flow cytometry, oil red O, Alizarin Red S, and clone formation assays. Gene expression was detected by quantitative real-time PCR (qRT-PCR) and western blotting. Exosomes were isolated and characterized by nanoparticle tracking analysis (NTA) and transmission electron microscope (TEM), and their uptake was measured adopting the 3,3'-dioctadecyloxacarbocyanine perchlorate (DIO) probe. In vitro and in vivo ALI models were established exploiting lipopolysaccharide (LPS). Moreover, the cell viability, cytotoxicity, inflammatory response, cell apoptosis, oxidative stress markers, mitochondrial membrane potential, and mitochondrial DNA (mtDNA) and adenosine 5'-triphosphate (ATP) levels, as well as hematoxylin-eosin (H&E) staining were analyzed to evaluate the effects of GSTP1-modified exosomes on ALI. ADMSCs were positive for CD90 and CD73 and negative for CD34 and CD45.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research